Morphologically Typical and Atypical B-Cell Chronic Lymphocytic Leukemias Display a Different Pattern of Surface Antigenic Density
- 1 January 2001
- journal article
- research article
- Published by Taylor & Francis Ltd in Leukemia & Lymphoma
- Vol. 42 (4), 649-654
- https://doi.org/10.3109/10428190109099325
Abstract
Recent evidences suggest that B-cell chronic lymphocytic leukemia (B-CLL) may have heterogeneous biological and clinical features. Immunological phenotype may be useful for distinguishing these different forms of disease. We used a quantitative flow cytometric approach to analyze the expression of several membrane molecules (CD19, CD20, CD22, CD23, CD11c, CD5, CD79b) commonly used to diagnose and characterize B-CLL in a choort of 84 consecutive B-CLL patients diagnosed according to morphological and immunological findings. We found that morphologically so-called "atypical" B-CLL displayed a significantly higher number of CD20 and CD22 molecules than typical forms. On the other hand, CD19 was found to be more expressed in typical B-CLL, although without reaching statistical significance. Finally, no difference was detected with respect to CD23, CD79b, CD11c and CD5 number of molecules/per cell between typical and atypical B-CLL. Other clinico-biological features, such as surface membrane immunoglobulin density, percentage of CD79b and FMC7 expression, peripheral blood lymphocytosis, trisomy 12 and advanced clinical stages were also found to be more frequent in atypical B-CLL. In conclusion, our data confirm the hypothesis that atypical B-CLL is a disease sustained by more mature B-cells, closely related but, at the same time, clearly distincted from neoplastic cells of typical B-CLL.Keywords
This publication has 13 references indexed in Scilit:
- Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disordersAmerican Journal of Hematology, 2000
- Chronic Lymphoproliferative Disorders: An Integrated Point of View for the Differential DiagnosisLeukemia & Lymphoma, 2000
- The Concept of Typical and Atypical Chronic Lymphocytic LeukaemiaLeukemia & Lymphoma, 1999
- Terminology and nomenclature for standardization in quantitative fluorescence cytometryCytometry, 1998
- Levels of expression of CD19 and CD20 in chronic B cell leukaemiasJournal of Clinical Pathology, 1998
- Heterogeneity and Clinical Relevance of the Intensity of CD20 and Immunoglobulin Light-Chain Expression in B-Cell Chronic Lymphocytic LeukemiaAmerican Journal of Clinical Pathology, 1996
- Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patientsBritish Journal of Haematology, 1996
- Quantitative flow cytometry can distinguish between normal and leukaemic B-cell precursorsBritish Journal of Haematology, 1995
- Clinical, biological, and immunophenotypical characteristics of B‐cell chronic lymphocytic leukemia with trisomy 12 by fluorescence in situ hybridizationCytometry, 1995
- Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.Journal of Clinical Pathology, 1989